Atropos Health
Total Raised
$50.33MInvestors Count
13Deal Terms
1Funding, Valuation & Revenue
6 Fundings
Atropos Health has raised $50.33M over 6 rounds.
Atropos Health's latest funding round was a Series B for $33M on May 23, 2024.
Atropos Health's latest post-money valuation is from May 2024.
Sign up for a free demo to see Atropos Health's valuations in May 2024 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
5/23/2024 | Series B | $33M | 4 | |||
8/10/2023 | Series A - II | |||||
8/4/2022 | Series A | |||||
12/10/2020 | Seed | |||||
12/10/2020 | Incubator/Accelerator |
Date | 5/23/2024 | 8/10/2023 | 8/4/2022 | 12/10/2020 | 12/10/2020 |
|---|---|---|---|---|---|
Round | Series B | Series A - II | Series A | Seed | Incubator/Accelerator |
Amount | $33M | ||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 4 |
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Atropos Health Deal Terms
1 Deal Term
Atropos Health's deal structure is available for 1 funding round, including their Series B from May 23, 2024.
Round | Series B |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B |
Atropos Health Investors
13 Investors
Atropos Health has 13 investors. Breyer Capital invested in Atropos Health's Series B funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
8/4/2022 | 5/23/2024 | 3 Series A, Series A - II (2023), Series B (2024) | Venture Capital | Texas | ||
8/10/2023 | 5/23/2024 | 2 Series A - II, Series B (2024) | Corporate Venture | California | ||
8/4/2022 | 5/23/2024 | 2 Series A, Series B (2024) | Family Office | California | ||
Corporate Venture | Pennsylvania | |||||
Corporate Venture | California |
First funding | 8/4/2022 | 8/10/2023 | 8/4/2022 | ||
|---|---|---|---|---|---|
Last Funding | 5/23/2024 | 5/23/2024 | 5/23/2024 | ||
Investor | |||||
Rounds | 3 Series A, Series A - II (2023), Series B (2024) | 2 Series A - II, Series B (2024) | 2 Series A, Series B (2024) | ||
Board Seats | |||||
Type | Venture Capital | Corporate Venture | Family Office | Corporate Venture | Corporate Venture |
Location | Texas | California | California | Pennsylvania | California |
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Compare Atropos Health to Competitors
Holmusk is a data analytics and health technology company that focuses on behavioral health within the healthcare sector. The company offers a real-world evidence platform that combines a behavioral health database with analytics and digital solutions to support research and care. Holmusk's services include HolCare EHR+, an electronic health records platform with measurement-based care, and NeuroBlu Research, a data analytics solution for building patient cohorts and exploring datasets. It was founded in 2015 and is based in New York, New York.
Evidation focuses on harnessing real-world health data to measure and improve health outcomes. The company offers a digital health measurement and engagement platform that utilizes data science and machine learning to provide health guidance, treatments, and tools. Evidation primarily serves life sciences companies, government bodies, and academic institutions. It was founded in 2012 and is based in San Mateo, California.
Datavant specializes in data connectivity and logistics for the healthcare sector. The company offers services including real-world data connectivity and data transformation to facilitate the secure and compliant movement of health information. It serves health plans, healthcare providers, life sciences, and government entities by providing solutions for improved healthcare data management. The company was founded in 2017 and is based in Phoenix, Arizona.
Komodo Health specializes in healthcare analytics and operates within the healthcare technology sector. The company offers a platform that provides insights by analyzing a range of healthcare data, aiming to improve patient care and reduce disease burden. Komodo Health primarily serves life sciences companies, healthcare practitioners, payers, and patient advocacy groups with its suite of software applications designed to deliver value in healthcare through data-driven insights. It was founded in 2014 and is based in San Francisco, California.
MediMergent focuses on the collection and analysis of Real-World Evidence (RWE) in the healthcare field. The company provides solutions for patient engagement, clinical trial support, and population health analytics, aimed at integrating patient feedback into healthcare decision-making. MediMergent serves pharmaceutical and life science companies, health insurers, payers, and data analytics aggregators. It was founded in 2014 and is based in Rockville, Maryland.
Decode Health specializes in providing an AI platform as a service (PaaS) that focuses on precision medicine within the healthcare sector. The company offers solutions for pharmaceutical, diagnostic, and technology companies by leveraging multiomics, clinical data, social determinants of health, and other healthcare data sources to deliver actionable insights and accelerate research and development. Decode Health primarily serves the pharmaceutical industry, diagnostic research, and technology platforms seeking to enhance disease management and outcomes. It was founded in 2019 and is based in Nashville, Tennessee.
Loading...